Chronic Kidney Disease
Chronic kidney disease (CKD) is a leading cause of mortality and morbidity that can lead to needing haemodialysis and kidney transplant. Join Professor Hiddo Heerspink, Professor Vlado Perkovic and Dr George Bakris and explore:
- CKD symptoms, stages, and pathophysiology of CKD from renal function to nephropathy
- The diagnosis of CKD, including the signs of kidney disease from early to late CKD stages
- Novel treatments for CKD to help delay disease progression and the need for renal transplantation
Note: Victor is a theoretical patient case for educational purposes only.
How do you manage the symptoms of kidney disease? Explore the progression of kidney disease through various CKD stages to kidney failure and learn about the need for earlier diagnosis. Also find out the latest guidance on the management of kidney disease and its comorbidities, such as diabetic kidney disease (DKD), as well as treatments like sodium-glucose transport protein 2 (SGLT2) inhibitors, renin-angiotensin-aldosterone system inhibitors (RAASi), and renal dialysis.
This Learning Zone was developed by EPG Health with expert insights provided by Professor Hiddo Heerspink from the University Medical Centre Groningen in the Netherlands, Professor Vlado Perkovic from the University of New South Wales in Australia and Dr George Bakris from the University of Chicago Medicine in the US.
Explore CKD Treatment Strategies
Review evidence-based therapies to manage progression and improve outcomes.
Expert Insights: Chronic Kidney Disease (CKD)
Prof. Hiddo Heerspink – Clinical Pharmacologist
Affiliations:
- University Medical Center Groningen, Netherlands
- George Institute for Global Health, Sydney, Australia
My work centres around clinical trials and development of new drugs for the treatment of chronic kidney disease.
Clinical Relevance: Clinical trials and drug development for CKD
Prof. Vlado Perkovic – Dean of Medicine & Nephrologist
Affiliations:
- University of New South Wales, Sydney, Australia
- Royal North Shore Hospital, Sydney
I've undertaken a large number of clinical trials aiming to prevent the progression of kidney disease and also prevent its complications including some of the SGLT2 inhibitor trials.
Clinical Relevance: Preventing CKD progression and complications through clinical trials
Dr. George Bakris – Professor of Medicine
Affiliations:
- University of Chicago Medicine
- American Heart Association Comprehensive Hypertension Center
We see people with advanced kidney disease, primarily diabetes, and focus on resistant hypertension and difficult to control blood pressure.
Clinical Relevance: Managing advanced CKD, diabetes, and resistant hypertension
This content has been developed independently by Medthority who previously received educational funding from AstraZeneca in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.